Andrew Read

Andrew Read has over 19 years of work experience in the pharmaceutical industry. Andrew is currently the Director of Manufacturing Science and Technology at the Center for Breakthrough Medicines, a position they have held since March 2022. Prior to this role, Andrew worked at GSK for almost 19 years, starting as a Manager of Process Technologies in August 2003. Andrew then became an Associate Director of Process Technology at GlaxoSmithKline in February 2022 before moving on to their current position.

Andrew Read attended Millersville University of Pennsylvania from 1995 to 1999. Andrew then pursued their MBA at Saint Joseph's University - Erivan K. Haub School of Business from 2006 to 2013.